デフォルト表紙
市場調査レポート
商品コード
1679381

医薬品脂質ベース賦形剤の世界市場:市場規模・シェア・動向分析 (賦形剤の種類別・製品用途別・疾患用途別・産業用途別・年齢層別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)

Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report By Excipient Type, By Product Applications, By Disease Application, By Industry Application, By Age Group, By End-use, By Region, And Segment Forecasts, 2025 - 2030


出版日
ページ情報
英文 400 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
医薬品脂質ベース賦形剤の世界市場:市場規模・シェア・動向分析 (賦形剤の種類別・製品用途別・疾患用途別・産業用途別・年齢層別・最終用途別・地域別)、セグメント別予測 (2025年~2030年)
出版日: 2025年02月20日
発行: Grand View Research
ページ情報: 英文 400 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品脂質ベース賦形剤市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の医薬品脂質ベース賦形剤の市場規模は2030年までに24億2,000万米ドルに達し、予測期間中にCAGR 4.8%で拡大すると予測されています。

パイプライン候補の87%を占める難溶性薬剤候補の増加により、高度な賦形剤ソリューションの採用が進んでいます。固体脂質ナノ粒子や自己乳化型ドラッグデリバリーシステムなどの脂質ベースの賦形剤は、複雑な分子にとって不可欠なものとなり、製剤化の課題に効果的に対処しています。この急増は、薬剤のバイオアベイラビリティと有効性を高める革新的なソリューションに対する製薬業界のニーズを反映しています。

脂質ベース賦形剤の統合は、COVID-19パンデミックの際に強調されたように、mRNAワクチンと遺伝子治療に革命をもたらしました。さらに、主要医薬品の特許切れにより、費用対効果の高い賦形剤への需要がさらに高まっています。これらの要因は、現代の医薬品開発における脂質賦形剤の変革的な影響と、ドラッグデリバリーの革新を促進する役割を強調しています。

人工知能(AI)と製剤技術の進歩は、脂質添加剤市場の成長にさらに貢献しています。AI主導のモデリングは脂質ベースの製剤を加速させ、予測可能性を高め、市場投入までの時間を短縮します。規制機関は脂質賦形剤に高い期待を寄せており、純度と安全特性に着目することで患者の安全を優先し、最終的に医薬品の品質と有効性を確保しています。

医薬品脂質ベース賦形剤市場:分析概要

  • 賦形剤に基づくと、脂質ドラッグデリバリーの進歩、栄養補助食品の使用、持続可能な成分への需要により、2024年には油脂賦形剤が総売上の40.5%を占め、市場を独占しました。
  • レシチンとリン脂質セグメントは、予測期間中に堅調なCAGRで成長すると予測されています。
  • 製品用途別では、局所用製剤が2024年に最大の収益シェアで市場をリードしましたが、眼科用途は予測期間中に6.7%の最速成長率が見込まれます。
  • 疾患別では、脂質ベースの賦形剤の腫瘍学的用途が2024年に最大の収益を獲得しました。
  • 業種別では、脂質賦形剤メーカーとサプリメントに特化した製薬企業との戦略的パートナーシップに後押しされ、栄養補助食品・その他分野が予測期間中に最も速いCAGRを記録する見込みです。
  • 加齢に関連した症状が広まるにつれて、高齢者向け製品(65歳以上)分野は予測期間中に5.0%以上のCAGRを記録する見込みです。
  • 最終用途別では、製薬メーカーが2024年の市場において支配的なエンドユーザーとして浮上し、総売上の64.9%を占めています。
  • 2024年4月、IOI Oleo GmbHは化粧品業界向けにDYNASAN CrystalCONTROL Lを発売しました。この製品はスティック製剤の「ブルーミング」効果に対応し、製品の安定性と美観を向上させ、世界的に心配のないプロセスを実現します。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 メーカー側の展望:市場の変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
    • 市場機会の分析
    • 市場の課題の分析
  • 医薬品脂質ベース賦形剤市場:分析ツール
    • ポーターのファイブフォース分析
  • 顧客のニーズ、問題点、利益の分析

第4章 医薬品脂質ベース賦形剤メーカーの競合情勢

  • 企業/競合の分類(主要なイノベーター、市場リーダー、新興企業)
  • 脂質ベース賦形剤メーカーの企業プロファイル
    • ABITEC(ABF INGREDIENTS).
    • BASF CORPORATION
    • GATTEFOSSE
    • CORDENPHARMA
    • LIPOID GMBH
    • IOI OLEO GMBH
    • CRODA INTERNATIONAL PLC
    • EVONIK INDUSTRIES AG
    • ASHLAND
    • MERCK KGAA
  • 企業市場シェア分析(2024年)
  • ヒートマップ分析

第5章 エンドユーザーの視点:市場の変動要因・動向・範囲

  • 医薬品脂質ベース賦形剤市場の展望:エンドユーザー(購入者/消費者企業)の視点
    • 市場促進要因の分析
    • 市場機会の分析
    • 市場抑制要因の分析
    • 市場の課題の分析
  • 医薬品脂質ベース賦形剤市場の分析ツール
    • ポーターのファイブフォース分析

第6章 エンドユーザー分析(バイヤー/消費者企業)の競合情勢

  • 企業/競合の分類(主要なイノベーター、市場リーダー、新興企業)
  • バイヤー/消費者企業プロファイル
    • TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • VIATRIS INC.(FORMERLY MYLAN)
    • SANDOZ(A DIVISION OF NOVARTIS)
    • SUN PHARMACEUTICAL INDUSTRIES LTD.
    • CIPLA LTD.
    • DR. REDDY'S LABORATORIES LTD.
    • AUROBINDO PHARMA LTD.
    • LUPIN LTD.
    • ZYDUS LIFESCIENCES LTD.(FORMERLY CADILA)
    • HIKMA PHARMACEUTICALS PLC
  • Heatmap analysis

第7章 医薬品脂質ベース賦形剤市場:賦形剤の種類別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:賦形剤の種類別の分析
  • 賦形剤の種類別 (2018~2030年)
    • 油脂
    • 水素添加植物油
    • GMCC
    • ハードファット
    • 中鎖脂肪酸トリグリセリド(MCTS)
    • レシチンとリン脂質
    • オレイン酸ナトリウム
    • カプリカプリル酸モノジグリセリド
    • その他の賦形剤の種類

第8章 医薬品脂質ベース賦形剤市場:製品用途別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:製品用途別の分析
  • 製品用途別 (2018~2030年)
    • 経口製剤
    • 非経口
    • 局所的応用
    • 眼科用途
    • 坐薬
    • その他の製品用途

第9章 医薬品脂質ベース賦形剤市場:疾患用途別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:疾患用途別の分析
  • 疾患用途別 (2018~2030年)
    • 心血管疾患
    • 神経疾患
    • 腫瘍学
    • 代謝障害
    • ホルモン療法
    • 感染症
    • その他の疾患への応用

第10章 医薬品脂質ベース賦形剤市場:製品産業別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:製品産業別の分析
  • 製品産業別 (2018~2030年)
    • 医薬品(OTC・RX)
    • 栄養補助食品(栄養補助食品、その他)

第11章 医薬品脂質ベース賦形剤市場:各年齢層向け製品別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:各年齢層向け製品別
  • 各年齢層向け製品別 (2018~2030年)
    • 小児向け製品(0~18歳)
    • 成人向け製品(19~64歳)
    • 高齢者向け製品(65歳以上)

第12章 医薬品脂質ベース賦形剤市場、最終用途別 (2018~2030年)

  • 医薬品脂質ベース賦形剤市場:最終用途製品分析
  • 最終用途別 (2018~2030年)
    • 製薬メーカー
    • 契約開発製造組織(CDMOS)
    • その他

第13章 医薬品脂質ベース賦形剤市場:地域別の推定・動向分析

  • 医薬品脂質ベース賦形剤市場:地域別の展望
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 中国
    • インド
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • ヨルダン
    • エジプト
    • イラン
    • クウェート

第14章 競合情勢

  • 市場参入企業の分類
  • 企業市況分析/ヒープマップ分析
  • 戦略マッピング
    • 企業合併・買収 (M&A)
    • パートナーシップとコラボレーション
    • その他
  • 企業プロファイル
    • ABITEC Corporation
    • BASF
    • Gattefosse
    • CordenPharma
    • Lipoid
    • IOI Oleo GmbH
    • Croda International
    • Evonik Industries
    • Ashland
    • Merck KGaA
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Company market share, 2024
  • Table 4. Projected number of adults 50 years and older with chronic disease in the U.S. (in Million)
  • Table 5. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by excipient type, 2018 - 2030 (USD Million)
  • Table 6. Oil excipient market analysis
  • Table 7. Sesame oil excipient market analysis
  • Table 8. Soybean excipient market analysis
  • Table 9. Sunflower excipient market analysis
  • Table 10. Linseed oil /flaxseed oil excipient market analysis
  • Table 11. Safflower oil excipient market analysis
  • Table 12. Coconut oil excipient market analysis
  • Table 13. Peanut oil excipient market analysis
  • Table 14. Corn oil/ maize oil excipient market analysis
  • Table 15. Olive oil excipient market analysis
  • Table 16. Almond oil excipient market analysis
  • Table 17. Castor oil excipient market analysis
  • Table 18. Cotton seed oil excipient market analysis
  • Table 19. Grape seed oil excipient market analysis
  • Table 20. Cotton seed oil excipient market analysis
  • Table 21. Hydrogenated vegetable oils excipient market analysis
  • Table 22. GMCC excipient market analysis
  • Table 23. Hard fat vegetable oils excipient market analysis
  • Table 24. MCT excipient market analysis
  • Table 25. Lecithin and phospholipids excipient market analysis
  • Table 26. Sodium oleate excipient market analysis
  • Table 27. Capri caprylic mono diglyceride excipient market analysis
  • Table 28. Other types excipient market analysis
  • Table 29. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product application, 2018 - 2030 (USD Million)
  • Table 30. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by Disease application, 2018 - 2030 (USD Million)
  • Table 31. Global heart & circulatory disease prevalence in 2021 and deaths 2021
  • Table 32. Global risk factors for heart & circulatory diseases (CVD)
  • Table 33. Alzheimer's disease prevalence in various countries
  • Table 34. Parkinson's disease prevalence in various countries
  • Table 35. New cases and deaths for 36 cancers and all cancers combined in 2022
  • Table 36. Incidence and mortality rates (age-standardized rate per 100,000, cumulative risk) for 24 world areas and by sex for all cancers combined (including nonmelanoma skin cancer except basal cell carcinoma) in 2022.
  • Table 37. Estimated number, percentage, and awareness of prediabetes among adults aged 18 years or older, U.S., 2017 - 2020 and 2021
  • Table 38. Global diabetes data report 2000 - 2045
  • Table 39. Prevalence of some of the endocrine disorders in 2022
  • Table 40. Global and regional estimates of TB incidence, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 41. Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2023
  • Table 42. Subgroup analysis of the prevalence of Dry Eye Disorder in Asia
  • Table 43. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product industry, 2018 - 2030 (USD Million)
  • Table 44. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by age-based product, 2018 - 2030 (USD Million)
  • Table 45. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by end-use, 2018 - 2030 (USD Million)
  • Table 46. Key lipid excipients manufacturers in the U.S.
  • Table 47. Key end user of lipid excipients in the U.S.
  • Table 48. Key lipid excipients manufacturers in the Canada
  • Table 49. Key end user of lipid excipients in the Canada
  • Table 50. Key lipid excipients manufacturers in the Mexico
  • Table 51. Key end user of lipid excipients in the Mexico
  • Table 52. Key lipid excipients manufacturers in the UK
  • Table 53. Key end user of lipid excipients in the UK
  • Table 54. Key lipid excipients manufacturers in the Germany
  • Table 55. Key end user of lipid excipients in the Germany
  • Table 56. Key lipid excipients manufacturers in the France
  • Table 57. Key end user of lipid excipients in the France
  • Table 58. Key lipid excipients manufacturers in Itay.
  • Table 59. Key End users of lipid excipients in Italy
  • Table 60. Key lipid excipients manufacturers in Spain.
  • Table 61. Key End users of lipid excipients in Spain
  • Table 62. Key lipid excipients manufacturers in the Norway.
  • Table 63. Key End users of lipid excipients in the Norway
  • Table 64. Key lipid excipients manufacturers in Sweden.
  • Table 65. Key End users of lipid excipients in Sweden
  • Table 66. Key lipid excipients manufacturers in Denmark.
  • Table 67. Key End users of lipid excipients in Denmark
  • Table 68. Key lipid excipients manufacturers in China.
  • Table 69. Key End users of lipid excipients in China
  • Table 70. Key lipid excipients manufacturers in India.
  • Table 71. Key End users of lipid excipients in India
  • Table 72. Key lipid excipients manufacturers in the South Korea
  • Table 73. Key end user of lipid excipients in the South Korea
  • Table 74. Key lipid excipients manufacturers in Brazil.
  • Table 75. Key End users of lipid excipients in Brazil
  • Table 76. Key lipid excipients manufacturers in Argentina.
  • Table 77. Key End users of lipid excipients in Argentina
  • Table 78. Key lipid excipients manufacturers in South Africa.
  • Table 79. Key End users of lipid excipients in South Africa
  • Table 80. Key lipid excipients manufacturers in Saudi Arabia.
  • Table 81. Key End users of lipid excipients in Saudi Arabia
  • Table 82. Key lipid excipients manufacturers in UAE.
  • Table 83. Key End users of lipid excipients in UAE
  • Table 84. Key lipid excipients manufacturers in Jordan.
  • Table 85. Key End users of lipid excipients in Jordan
  • Table 86. Key lipid excipients manufacturers in Egypt.
  • Table 87. Key End users of lipid excipients in Egypt
  • Table 88. Key lipid excipients manufacturers in Iran.
  • Table 89. Key End users of lipid excipients in Iran
  • Table 90. Key End users of lipid excipients in Kuwait

List of Figures

  • Fig. 1 Pharmaceutical lipid-based excipients market: Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Segment snapshot (Excipient type)
  • Fig. 10 Segment snapshot (Product Application)
  • Fig. 11 Segment snapshot (Disease Application)
  • Fig. 12 Segment snapshot (Product industry & age-based product)
  • Fig. 13 Segment snapshot (Product industry & age-based product)
  • Fig. 14 Segment snapshot (End-use)
  • Fig. 15 Competitive landscape
  • Fig. 16 Excipients market estimates and forecast, 2018-2030, USD Million
  • Fig. 17 Market dynamics
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 20 Company market share analysis, 2024
  • Fig. 21 Heatmap analysis
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • Fig. 24 Heatmap analysis
  • Fig. 25 Pharmaceutical Lipid-Based Excipients Market: Excipient Type outlook and key takeaways
  • Fig. 26 Pharmaceutical Lipid-Based Excipients Market: Excipient type movement analysis
  • Fig. 27 Oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Sesame oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Soybean oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Sunflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Linseed oil /flaxseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Safflower oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Coconut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Arachis oil / peanut oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Corn oil / maize oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Olive oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Almond oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Castor oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Grapeseed oil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Other oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Hydrogenated vegetable oils market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 GMCC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Hard fats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Medium Chain triglycerides (MCTs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Lecithin and phospholipids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Sodium oleate market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Capri caprylic mono diglyceride market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Other excipient types market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Pharmaceutical Lipid-Based Excipients Market: Product Application outlook and key takeaways
  • Fig. 50 Pharmaceutical Lipid-Based Excipients Market: Product application movement analysis
  • Fig. 51 Oral formulations market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Softgel capsules market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Solid dosage market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Small volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Large volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Creams market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Other topical applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Ophthalmic applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Ocular emulsions market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Rectal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 68 Vaginal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 69 Other Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Other product applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Pharmaceutical Lipid-Based Excipients Market: Disease Application outlook and key takeaways
  • Fig. 72 Pharmaceutical Lipid-Based Excipients Market: Disease Application movement analysis
  • Fig. 73 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Hormonal therapies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Other disease applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 80 Pharmaceutical Lipid-Based Excipients Market Product Industry outlook and key takeaways
  • Fig. 81 Pharmaceutical Lipid-Based Excipients Market: Product Industry movement analysis
  • Fig. 82 Pharmaceutical (OTC & Rx) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Nutraceutical (dietary supplements & other) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 84 Pharmaceutical Lipid-Based Excipients Market Age-Based Product outlook and key takeaways
  • Fig. 85 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product movement analysis
  • Fig. 86 Pediatric products (0-18 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Adult products (19-64 years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Geriatric products (65+ years) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 89 Pharmaceutical Lipid-Based Excipients Market End-Use outlook and key takeaways
  • Fig. 90 Pharmaceutical Lipid-Based Excipients Market: End-Use Product movement analysis
  • Fig. 91 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Contract Development and Manufacturing Organizations (CDMOs) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Other market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Pharmaceutical Lipid-Based Excipients Market, revenue, by region, 2024 & 2030 (USD million)
  • Fig. 95 Regional marketplace: Key takeaways
  • Fig. 96 Regional marketplace: Key takeaways
  • Fig. 97 North America pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 U.S. pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Canada pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Mexico pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030, USD Million
  • Fig. 104 Europe pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 UK pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Germany pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 France pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Italy pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Key country dynamics
  • Fig. 114 Spain pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 115 Key country dynamics
  • Fig. 116 Norway pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 117 Key country dynamics
  • Fig. 118 Sweden pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Denmark pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Rest of Europe pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 122 Asia Pacific pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 123 Key country dynamics
  • Fig. 124 China pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Key country dynamics
  • Fig. 126 India pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Key country dynamics
  • Fig. 128 South Korea pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Rest of Asia Pacific pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 130 Latin America pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Key country dynamics
  • Fig. 132 Brazil pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 Argentina pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 135 Rest of Latin America pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 136 MEA pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Key country dynamics
  • Fig. 138 South Africa pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 139 Key country dynamics
  • Fig. 140 Saudi Arabia pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Key country dynamics
  • Fig. 142 UAE pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 143 Key country dynamics
  • Fig. 144 Jordan pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 Key country dynamics
  • Fig. 146 Egypt pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 147 Key country dynamics
  • Fig. 148 Iran pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 Key country dynamics
  • Fig. 150 Kuwait pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Rest of MEA pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-525-4

Pharmaceutical Lipid-based Excipients Market Growth & Trends:

The global pharmaceutical lipid-based excipients market size is anticipated to reach USD 2.42 billion by 2030 and is anticipated to expand at a CAGR of 4.8% during the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of poorly soluble drug candidates, representing 87% of pipeline candidates, has driven the adoption of advanced excipient solutions. Lipid-based excipients such as solid lipid nanoparticles and self-emulsifying drug delivery systems have become essential for complex molecules, addressing formulation challenges effectively. This surge reflects the pharmaceutical industry's need for innovative solutions to enhance drug bioavailability and efficacy.

The integration of lipid-based excipients has revolutionized mRNA vaccines and gene therapies, as highlighted during the COVID-19 pandemic. Moreover, the demand for cost-effective excipients has further increased due to patent expirations for major pharmaceutical drugs. These factors underscore the transformative impact of lipid excipients on modern pharmaceutical development and their role in driving innovation in drug delivery.

Advancements in artificial intelligence (AI) and formulation technologies further contribute to the growth of the lipid excipients market. AI-driven modeling accelerates lipid based formulations, enhancing predictability and reducing time-to-market. Regulatory bodies maintain high expectations for lipid excipients, prioritizing patient safety by focusing on purity and safety characteristics, ultimately ensuring the quality and effectiveness of pharmaceutical products.

Pharmaceutical Lipid-based Excipients Market Report Highlights:

  • Based on excipients, oil excipients dominated the market in 2024, accounting for 40.5% of the total revenue due to advancements in lipid drug delivery, nutraceutical use, and demand for sustainable ingredients.
  • The lecithin and phospholipids segment is projected to grow at a robust CAGR over the forecast period.
  • Based on product applications, topical formulations led the market with the largest revenue share in 2024; however, ophthalmic applications are expected to grow at the fastest rate of 6.7% over the forecast period.
  • Based on disease, oncological applications of lipid-based excipients garnered the largest revenue in 2024, aided by a growing pipeline of targeted therapies and immunotherapies for cancer.
  • Based on industry, the nutraceutical (dietary supplements & others) segment is expected to witness the fastest CAGR over the forecast period, fueled by strategic partnerships between lipid excipient manufacturers and supplement-focused pharmaceutical companies.
  • As aging-related conditions become more widespread, the geriatric products (65+ years) segment is expected to witness the fastest CAGR of over 5.0% over the forecast period.
  • Based on end use, pharmaceutical manufacturers emerged as dominant end users in the market in 2024, accounting for 64.9% of the total revenue.
  • In April 2024, IOI Oleo GmbH launched DYNASAN CrystalCONTROL L for the cosmetics industry. This product addresses the "blooming" effect in stick formulations, improving product stability and aesthetics for a worry-free process globally.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Regional Scope
    • 1.1.2 Estimates And Forecast Timeline
    • 1.1.3 Objectives
    • 1.1.4 Objective - 1
    • 1.1.5 Objective - 2
    • 1.1.6 Objective - 3
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Market Evaluation Methodology:
  • 1.7 List Of Secondary Sources
  • 1.8 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot (Regional)
  • 2.2 Segment Snapshot (Excipient Type)
  • 2.3 Segment Snapshot (Product Application)
  • 2.4 Segment Snapshot (Disease Application)
  • 2.5 Segment Snapshot (Product Industry & Age-based Product)
  • 2.6 Segment Snapshot (Product Industry & Age-based Product)
  • 2.7 Segment Snapshot (End-use)
  • 2.8 Competitive Landscape

Chapter 3 Manufacturers Perspective: Market Variables, Trends, and Scope

  • 3.1 Pharmaceutical Lipid-Based Excipients Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 Excipient Market
    • 3.1.2 Ancillary Market Outlook
      • 3.1.2.1 Polymers Excipient Market
      • 3.1.2.2 Sugars Excipient Market
      • 3.1.2.3 Minerals Excipient Market
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
      • 3.2.1.1 Proliferation of Drug Candidates with Low Water Solubility and Bioavailability Challenges
      • 3.2.1.2 Growing Application of Lipid Excipients in Biologics and RNA-based Therapeutics
      • 3.2.1.3 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
    • 3.2.2 Market Opportunities Analysis
      • 3.2.2.1 Expansion of Pharmaceutical Manufacturing in Emerging Markets as a Growth Opportunity for Lipid Excipients
      • 3.2.2.2 Growth of Local Manufacturers Enhancing Competition and Innovation in the Lipid Excipients Market
    • 3.2.3 Market Restraint Analysis
      • 3.2.3.1 Price Sensitivity in Emerging Markets Restricting the Adoption of Premium Lipid Excipients
      • 3.2.3.2 Market Dominance by Key Players Restricting Entry and Innovation in Lipid Excipients Sector
    • 3.2.4 Market Challenges Analysis
      • 3.2.4.1 Substantial R&D Investment Requirements for Developing Novel Lipid Excipients and Delivery Systems
      • 3.2.4.2 Global Regulatory and Compliance Complexities Adding Operational Challenges for Lipid Excipients Manufacturers
  • 3.3 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 3.3.1 PORTER'S Five Forces Analysis
  • 3.4 Customer Needs, Pains, and Gains Analysis

Chapter 4 Manufacturers Competitive Landscape of Lipid-based Excipients

  • 4.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.2 Company Profiles for Manufacturers of Lipid Excipients
    • 4.2.1 ABITEC (ABF INGREDIENTS).
      • 4.2.1.1 Company Overview
      • 4.2.1.2 Financial Overview
      • 4.2.1.3 Product Overview
      • 4.2.1.4 Key Strategic initiatives
    • 4.2.2 BASF CORPORATION
      • 4.2.2.1 Company Overview
      • 4.2.2.2 Financial Overview
      • 4.2.2.3 Product Overview
      • 4.2.2.4 Strategic Initiatives
    • 4.2.3 GATTEFOSSE
      • 4.2.3.1 Company Overview
      • 4.2.3.2 Financial Overview
      • 4.2.3.3 Product Overview
      • 4.2.3.4 Strategic Initiatives
    • 4.2.4 CORDENPHARMA
      • 4.2.4.1 Company Overview
      • 4.2.4.2 Financial Overview
      • 4.2.4.3 Product Overview
      • 4.2.4.4 Strategic Initiatives
    • 4.2.5 LIPOID GMBH
      • 4.2.5.1 Company Overview
      • 4.2.5.2 Financial Overview
      • 4.2.5.3 product Overview
      • 4.2.5.4 Key Strategic Initiatives
    • 4.2.6 IOI OLEO GMBH
      • 4.2.6.1 Company overview
      • 4.2.6.2 Financial Overview
      • 4.2.6.3 Product Overview
      • 4.2.6.4 Strategic initiatives
    • 4.2.7 CRODA INTERNATIONAL PLC
      • 4.2.7.1 Company Overview
      • 4.2.7.2 Financial Overview
      • 4.2.7.3 Product Overview
      • 4.2.7.4 Strategic Initiatives
    • 4.2.8 EVONIK INDUSTRIES AG
      • 4.2.8.1 Company Overview
      • 4.2.8.2 Financial Overview
      • 4.2.8.3 Product Overview
      • 4.2.8.4 Strategic Initiatives
    • 4.2.9 ASHLAND
      • 4.2.9.1 Company Overview
      • 4.2.9.2 Financial Overview
      • 4.2.9.3 Product Overview
      • 4.2.9.4 Strategic Initiatives
    • 4.2.10 MERCK KGAA
      • 4.2.10.1 Company Overview
      • 4.2.10.2 Financial Overview: Thermo Fisher Scientific
      • 4.2.10.3 Product Overview
      • 4.2.10.4 Strategic Initiatives
  • 4.3 Company Market Share Analysis, 2024
  • 4.4 Heatmap analysis

Chapter 5 End User Perspective: Market Variables, Trends, and Scope

  • 5.1 Pharmaceutical Lipid-Based Excipients Market Outlook - End User (Buyer/Consumer Companies) Perspective
    • 5.1.1 Market Driver Analysis
      • 5.1.1.1 Innovation in formulation development
      • 5.1.1.2 End user companies are formulating drugs for pediatric, geriatric, and chronic disease markets
      • 5.1.1.3 The Influence of ESG Objectives on the Adoption of Sustainable Lipid Excipients by End Users
    • 5.1.2 Market Opportunities Analysis
      • 5.1.2.1 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
      • 5.1.2.2 Increasing prevalence of chronic diseases driving demand for lipid based formulations
    • 5.1.3 Market Restraint Analysis
      • 5.1.3.1 High R&D Costs, a Restraint for end use Pharmaceutical Companies Using Lipid-Based Excipients
      • 5.1.3.2 Regulatory Complexity
    • 5.1.4 Market Challenges Analysis
      • 5.1.4.1 Incompatibility with the active pharmaceutical ingredient (API)
      • 5.1.4.2 Stability and Shelf-Life Concerns
  • 5.2 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
    • 5.2.1 PORTER'S Five Forces Analysis

Chapter 6 End User Analysis (Buyer/Consumer Companies) Competitive Landscape

  • 6.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 6.2 Buyer/Consumer Company Profiles
    • 6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.1.1 Company Overview
      • 6.2.1.2 Financial Overview
      • 6.2.1.3 Product Overview
      • 6.2.1.4 Key Strategic initiatives
    • 6.2.2 VIATRIS INC. (FORMERLY MYLAN)
      • 6.2.2.1 Company Overview
      • 6.2.2.2 Financial Overview
      • 6.2.2.3 PRODUCT OVERVIEW
      • 6.2.2.4 Strategic Initiatives
    • 6.2.3 SANDOZ (A DIVISION OF NOVARTIS)
      • 6.2.3.1 Company Overview
      • 6.2.3.2 Financial Overview
      • 6.2.3.3 Product Overview
    • 6.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
      • 6.2.4.1 Company Overview
      • 6.2.4.2 Financial Overview
      • 6.2.4.3 Product Overview
    • 6.2.5 CIPLA LTD.
      • 6.2.5.1 Company Overview
      • 6.2.5.2 Financial Overview
      • 6.2.5.3 product Overview
      • 6.2.5.4 Key Strategic Initiatives
    • 6.2.6 DR. REDDY'S LABORATORIES LTD.
      • 6.2.6.1 Company overview
      • 6.2.6.2 Financial Overview
      • 6.2.6.3 Product Overview
      • 6.2.6.4 Strategic initiatives
    • 6.2.7 AUROBINDO PHARMA LTD.
      • 6.2.7.1 Company Overview
      • 6.2.7.2 Financial Overview
      • 6.2.7.3 Product Overview
      • 6.2.7.4 Strategic Initiatives
    • 6.2.8 LUPIN LTD.
      • 6.2.8.1 Company Overview
      • 6.2.8.2 Financial Overview
      • 6.2.8.3 Product Overview
    • 6.2.9 ZYDUS LIFESCIENCES LTD. (FORMERLY CADILA)
      • 6.2.9.1 Company Overview
      • 6.2.9.2 Financial Overview
      • 6.2.9.3 Product Overview
      • 6.2.9.4 Strategic Initiatives
    • 6.2.10 HIKMA PHARMACEUTICALS PLC
      • 6.2.10.1 Company Overview
      • 6.2.10.2 Financial Overview: Hikma Pharmaceuticals PLC
      • 6.2.10.3 Product Overview
  • 6.3 Heatmap analysis

Chapter 7 Pharmaceutical Lipid-Based Excipients Market, By Excipient Type, 2018 - 2030 (USD Million)

  • 7.1 Pharmaceutical Lipid-Based Excipients Market: Excipient Type Analysis
  • 7.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Excipient Type, 2018 - 2030 (USD Million)
    • 7.2.1 Oils
      • 7.2.1.1 Sesame Oil
      • 7.2.1.2 Soybean Oil
      • 7.2.1.3 Sunflower Oil
      • 7.2.1.4 Linseed Oil /Flaxseed Oil
      • 7.2.1.5 Safflower Oil
      • 7.2.1.6 Coconut Oil
      • 7.2.1.7 Arachis Oil / Peanut Oil
      • 7.2.1.8 Corn Oil / Maize Oil
      • 7.2.1.9 Olive Oil
      • 7.2.1.10 Almond Oil
      • 7.2.1.11 Castor Oil
      • 7.2.1.12 Cotton Seed Oil
      • 7.2.1.13 Grapeseed Oil
      • 7.2.1.14 Other Oils
    • 7.2.2 Hydrogenated Vegetable Oils
    • 7.2.3 GMCC
    • 7.2.4 Hard Fats
    • 7.2.5 Medium Chain Triglycerides (MCTS)
    • 7.2.6 Lecithin And Phospholipids
    • 7.2.7 Sodium Oleate
    • 7.2.8 Capri Caprylic Mono Diglyceride
    • 7.2.9 Other Excipient Types

Chapter 8 Pharmaceutical Lipid-Based Excipients Market, By Product Applications, 2018 - 2030 (USD Million)

  • 8.1 Pharmaceutical Lipid-Based Excipients Market: Product Application Analysis
  • 8.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Application, 2018 - 2030 (USD Million)
    • 8.2.1 Oral Formulations
      • 8.2.1.1 Softgel Capsules
      • 8.2.1.2 Solid Dosage
      • 8.2.1.3 Liquid Oral
      • 8.2.1.4 Solid Lipid Nanoparticles (Slns)
    • 8.2.2 Parenteral
      • 8.2.2.1 Small Volume Parenteral
      • 8.2.2.2 Large Volume Parenteral
    • 8.2.3 Topical Applications
      • 8.2.3.1 Creams
      • 8.2.3.2 Ointments
      • 8.2.3.3 Other Topical Applications
    • 8.2.4 Ophthalmic Applications
      • 8.2.4.1 Eye Drops
      • 8.2.4.2 Ocular Emulsions
    • 8.2.5 Suppositories
      • 8.2.5.1 Rectal Suppositories
      • 8.2.5.2 Vaginal Suppositories
      • 8.2.5.3 Other Suppositories
    • 8.2.6 Other Product Applications

Chapter 9 Pharmaceutical Lipid-Based Excipients Market, By Disease Application, 2018 - 2030 (USD Million)

  • 9.1 Pharmaceutical Lipid-Based Excipients Market: Disease Application Analysis
  • 9.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Disease Application, 2018 - 2030 (USD Million)
    • 9.2.1 Cardiovascular Diseases
    • 9.2.2 Neurological Disorders
    • 9.2.3 Oncology
    • 9.2.4 Metabolic Disorders
    • 9.2.5 Hormonal Therapies
    • 9.2.6 Infectious Diseases
    • 9.2.7 Other Disease Applications

Chapter 10 Pharmaceutical Lipid-Based Excipients Market, By Product Industry, 2018 - 2030 (USD Million)

  • 10.1 Pharmaceutical Lipid-Based Excipients Market: Product Industry Analysis
  • 10.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Industry, 2018 - 2030 (USD Million)
    • 10.2.1 Pharmaceutical (OTC & RX)
    • 10.2.2 Nutraceutical (Dietary Supplements & Other)

Chapter 11 Pharmaceutical Lipid-Based Excipients Market, By Age-Based Product, 2018 - 2030 (USD Million)

  • 11.1 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product Analysis
  • 11.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Age-Based Product, 2018 - 2030 (USD Million)
    • 11.2.1 Pediatric Products (0-18 Years)
    • 11.2.2 Adult Products (19-64 Years)
    • 11.2.3 Geriatric Products (65+ Years)

Chapter 12 Pharmaceutical Lipid-Based Excipients Market, By End-Use, 2018 - 2030 (USD Million)

  • 12.1 Pharmaceutical Lipid-Based Excipients Market: End-Use Product Analysis
  • 12.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by End-Use, 2018 - 2030 (USD Million)
    • 12.2.1 Pharmaceutical Manufacturers
    • 12.2.2 Contract Development And Manufacturing Organizations (CDMOS)
    • 12.2.3 Other

Chapter 13 Pharmaceutical Lipid-Based Excipients Market: Regional Estimates and Trend Analysis

  • 13.1 Pharmaceutical Lipid-Based Excipients Market: Regional Outlook
  • 13.2 North America
    • 13.2.1 North America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.2.2 U.S.
      • 13.2.2.1 Key Country Dynamics
      • 13.2.2.2 U.S. Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.2.3 Competitive/Market Scenario
      • 13.2.2.4 Regulatory Framework
    • 13.2.3 Canada
      • 13.2.3.1 Key Country Dynamics
      • 13.2.3.2 Canada Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 13.2.3.3 Competitive/Market Scenario
      • 13.2.3.4 Regulatory Framework
    • 13.2.4 Mexico
      • 13.2.4.1 Key Country Dynamics
      • 13.2.4.2 Mexico Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.2.4.3 Competitive/Market Scenario
      • 13.2.4.4 Regulatory Framework
  • 13.3 Europe
    • 13.3.1 Europe Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.3.2 UK
      • 13.3.2.1 Key Country Dynamics
      • 13.3.2.2 UK pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.2.3 Competitive/Market Scenario
      • 13.3.2.4 Regulatory Framework
    • 13.3.3 Germany
      • 13.3.3.1 Key Country Dynamics
      • 13.3.3.2 Germany pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.3.3 Competitive/Market Scenario
      • 13.3.3.4 Regulatory Framework
    • 13.3.4 France
      • 13.3.4.1 Key Country Dynamics
      • 13.3.4.2 France pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.4.3 Competitive/Market Scenario
      • 13.3.4.4 Regulatory Framework
    • 13.3.5 Italy
      • 13.3.5.1 Key Country Dynamics
      • 13.3.5.2 Italy pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.5.3 Competitive/Market Scenario
      • 13.3.5.4 Regulatory Framework
    • 13.3.6 Spain
      • 13.3.6.1 Key Country Dynamics
      • 13.3.6.2 Spain pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.6.3 Competitive/Market Scenario
      • 13.3.6.4 Regulatory Framework
    • 13.3.7 Norway
      • 13.3.7.1 Key Country Dynamics
      • 13.3.7.2 Norway Pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.7.3 Competitive/Market Scenario
      • 13.3.7.4 Regulatory Framework
    • 13.3.8 Sweden
      • 13.3.8.1 Key Country Dynamics
      • 13.3.8.2 Sweden pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.3.8.3 Competitive/Market Scenario
      • 13.3.8.4 Regulatory Framework
    • 13.3.9 Denmark
      • 13.3.9.1 Key Country Dynamics
      • 13.3.9.2 Denmark Pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
      • 13.3.9.3 Competitive/Market Scenario
      • 13.3.9.4 Regulatory Framework
    • 13.3.10 Rest Of Europe Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.4 Asia Pacific
    • 13.4.1 Asia Pacific Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.4.2 China
      • 13.4.2.1 Key Country Dynamics
      • 13.4.2.2 China pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.2.3 Competitive/Market Scenario
      • 13.4.2.4 Regulatory Framework
    • 13.4.3 India
      • 13.4.3.1 Key Country Dynamics
      • 13.4.3.2 India pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.4.3.3 Competitive/Market Scenario
      • 13.4.3.4 Regulatory Framework
    • 13.4.4 South Korea
      • 13.4.4.1 Key Country Dynamics
      • 13.4.4.2 South Korea pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 13.4.4.3 Competitive/Market Scenario
      • 13.4.4.4 Regulatory Framework
    • 13.4.5 Rest Of Asia Pacific Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.5 Latin America
    • 13.5.1 Latin America Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.5.2 Brazil
      • 13.5.2.1 Key Country Dynamics
      • 13.5.2.2 Brazil pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.2.3 Competitive/Market Scenario
      • 13.5.2.4 Regulatory Framework
    • 13.5.3 Argentina
      • 13.5.3.1 Key Country Dynamics
      • 13.5.3.2 Argentina pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.5.3.3 Competitive/Market Scenario
      • 13.5.3.4 Regulatory Framework
    • 13.5.4 Rest Of Latin America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 13.6 MEA
    • 13.6.1 MEA Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.6.2 South Africa
      • 13.6.2.1 Key Country Dynamics
      • 13.6.2.2 South Africa Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.2.3 Competitive/Market Scenario
      • 13.6.2.4 Regulatory Framework
    • 13.6.3 Saudi Arabia
      • 13.6.3.1 Key Country Dynamics
      • 13.6.3.2 Saudi Arabia pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.3.3 Competitive/Market Scenario
      • 13.6.3.4 Regulatory Framework
    • 13.6.4 UAE
      • 13.6.4.1 Key Country Dynamics
      • 13.6.4.2 UAE pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.4.3 Competitive/Market Scenario
      • 13.6.4.4 Regulatory Framework
    • 13.6.5 Jordan
      • 13.6.5.1 Key Country Dynamics
      • 13.6.5.2 Jordan pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.5.3 Competitive/Market Scenario
      • 13.6.5.4 Regulatory Framework
    • 13.6.6 Egypt
      • 13.6.6.1 Key Country Dynamics
      • 13.6.6.2 Egypt pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.6.3 Competitive/Market Scenario
      • 13.6.6.4 Regulatory Framework
    • 13.6.7 Iran
      • 13.6.7.1 Key Country Dynamics
      • 13.6.7.2 Iran pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.7.3 Competitive/Market Scenario
      • 13.6.7.4 Regulatory Framework
    • 13.6.8 Kuwait
      • 13.6.8.1 Key Country Dynamics
      • 13.6.8.2 Kuwait pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
      • 13.6.8.3 Competitive/Market Scenario
      • 13.6.8.4 Regulatory Framework
    • 13.6.9 Rest Of MEA Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 14 Competitive Landscape

  • 14.1. Market Participant Categorization
  • 14.2. Company Market Position Analysis/ Heap Map Analysis
  • 14.3. Strategy Mapping
    • 14.3.1. Mergers & Acquisitions
    • 14.3.2. Partnerships & Collaborations
    • 14.3.3. Others
  • 14.4. Company Profiles
    • 14.4.1. ABITEC Corporation
    • 14.4.2. BASF
    • 14.4.3. Gattefosse
    • 14.4.4. CordenPharma
    • 14.4.5. Lipoid
    • 14.4.6. IOI Oleo GmbH
    • 14.4.7. Croda International
    • 14.4.8. Evonik Industries
    • 14.4.9. Ashland
    • 14.4.10. Merck KGaA